Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Effect of Vitamin D Supplementation in Patients with Cardiometabolic Disorders- a Clinical Study in Ahmedabad Population


Affiliations
1 L.M. College of Pharmacy, Gujarat Technological University, Ahmedabad, Gujarat, India
2 Tej Hospital, Ahmedabad, Gujarat, India
     

   Subscribe/Renew Journal


Vitamin D deficiency and cardiometabolic disorders are very much widespread in worldwide, India and Ahmedabad region of Gujarat. It was the first study conducted among Gujarati ethnic group of Ahmedabad region, India. The aim of the study was to assess the effects of vitamin D supplementation on cardiometabolic disorders with vitamin D deficiency. The study was performed as an open labeled, randomized, parallel-group, single centric and prospective design at Tej Hospital, Ahmedabad, Gujarat. The dosage regimen of vitamin D supplementation was 60,000 IU/ week for 4 weeks and then 60,000IU once a month for 12 months. Our results showed that vitamin D supplementation causes significant decrease in systolic blood pressure (SBP) at 6 and 12 months as well as significant decrease in triglycerides (TG),very low density lipoprotein (VLDL), fasting blood glucose (FBG), post prandial blood glucose (PPBG) and glycosylated haemoglobin ( HbA1c) with significant increase in 25(OH)D level in vitamin D group at 12 months as compared with non-vitamin D group .Our findings supported that vitamin D deficiency may be a potential risk factor for cardiometabolic disorders and the dosage regimen of vitamin D supplementation is enough to achieve sufficiency and maintain 25(OH)D level which ultimately causes improvement in cardiometabolic disorders.

Keywords

Cardiometabolic disorders, Vitamin D, Clinical Study, Gujarati, Ahmedabad.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Srivastava AK. Challenges in the treatment of cardiometabolic syndrome. Indian Journal of Pharmacology. 2012; 44:155-156. doi.org/ 10.4103/0253-7613.93579.

  • Manikumar M. Monisha R. Comparative Study of Aerobic Exercise and Weight training on Metabolic Syndrome among Breast Cancer Survivors.Research Journal of Pharmacy and Technology. 2019; 12(6):2772-2775. doi.org/10.5958/0974-360X.2019.00465.7.

  • Parker J. Hashmi O. Dutton D. et al. Levels of vitamin D and cardiometabolic disorders: Systematic review and meta-analysis . Maturitas.2010;65:225-236. doi.org/ 10.1016/j.maturitas.2009.12.013.

  • Ibrahim NA. Saleh NM. Koprulu F et al. Metabolic Syndrome associated Risk factors: Findings among female undergraduate university students. Research Journal of Pharmacy and Technology. 2020;13(12):6093-6097. doi.org/ 10.5958/0974-360X.2020.01062.8.

  • Ramly M. Ming MF. Chinna K. et al. Effect of Vitamin D supplementation on Cardiometabolic Risks and Health-Related Quality of life among Urban premenopausal women in a Tropical Country- A Randomized Controlled Trial. PLOS ONE. 2014;9: e110-476. doi.org/10.1371/journal.pone.0110476.

  • Gunjaliya A. Patil R. Vaza J. et al. Prevalence of vitamin D deficiency in higher socioeconomical class of Ahmedabad, Gujarat, India. International Journal of Medical Science and Public Health .2014;4:617-620. doi.org/ 10.5455/ijmsph.2015.20112014124.

  • Harini K. Vishnu Priya V. Gayathri R. Awareness of Importance of Vitamin D Among Dental Students in a Dental School-A Survey. Research Journal of Pharmacy and Technology.2016;9(8):1133-1136. doi.org/ 10.5958/0974-360X.2016.00215.8.

  • Ritu G. and Gupta A. Vitamin D Deficiency in India: Prevalence, Causalities and Interventions. Nutrients. 2014;6:729-775. doi.org/ 10.3390/nu6020729.

  • Hariharan CV. Joshi SR. Vitamin D Status in India-Its Implications and Remedial Measures. Journal of the Association of Physicians of India. 2009;57:40-48.

  • Zittermann A . Vitamin D status, Supplementation, Cardiovascular Disease. Anticancer research.2018;38:1179-1186. doi.org/ 10.21873/anticanres.12338.

  • Kelishadi R. Salek S. Salek M. et al. Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial.Jornal de Pediatria. 2014;90:28-34. doi.org/ 10.1016/j.jped.2013.06.006.

  • Sofihussein HQ. Al- Naqshabandi AA. Sami HF. Saeed MMM. Effect of Vitamin D supplement on the risks of Cardiovascular disease in patients with type 2 diabetes in the Kurdistan Region of Iraq. Research Journal of Pharmacy and Technology. 2020;13(9):4125-4129. doi.org/ 10.5958/0974-360X.2020.00728.3.

  • Pittas AG, Chung M, et al. Systemic Review: Vitamin D and Cardiometabolic Outcomes. Annals of Internal Medicine .2010;152:307-314. doi.org/ 10.7326/0003-4819-152-5-201003020-00009.

  • Kadoura S. Alhalabi M. Nattouf AH. Effect of calcium and vitamin D supplements as an adjuvant therapy to metformin on lipid profile in vitamin D deficient/insufficient polycystic ovary syndrome patients: A Randomized, Placebo-Controlled Clinical Trial. Research Journal of Pharmacy and Technology. 2019;12(5):2327-2332. doi.org/ 10.5958/0974-360X.2019.00387.1.

  • Kaddoura S. Alhalabi M. Nattouf AH. The effect of calcium and vitamin D supplements as an adjuvant therapy to metformin on lipid profile in vitamin D deficient/insufficient polycystic ovary syndrome. Research Journal of Pharmacy and Technology.2019;12(4):1610-1614. doi.org/ 10.5958/0974-360X.2019.00268.3.

  • Norris KC . Barnett ME. et al. Rationale and design of a placebo controlled randomized trial to assess short term, high-dose oral cholecalciferol on select laboratory and genomic responses in African Americans with hypovitaminosis D. Contemporary Clinical Trials. 2018; 72:20-25. doi.org/ 10.1016/j.cct.2018.07.006.

  • Amanzholkyzy A. Nurgaliyeva RE. Kaldybayeva AT. et al. Biochemical variability of Vitamin D Receptor (Vdr) Gene and its Relationship with Bone Mineral Density in Children of the Western Region of the Republic of Kazakhstan. Research Journal of Pharmacy and Technology.2019;12(2):735-740. doi.org/ 10.5958/0974-360X.2019.00130.6.

  • Subashree R. Arjunkumar R. Vitamin D Deficiency in Periodontal Health. Research Journal of Pharmacy and Technology.2014;7(2):248-252

  • Pandya H. Lakhani JD. Dadhania J. Trivedi A. The Prevalence and Pattern of Dyslipidemia among Type 2 Diabetic Patients at Rural Based Hospital in Gujarat, India. Indian Journal of Clinical Practice. 2012,22:36-44.

  • Majumder A. Doshi B. Sheth F. Patel M. Shah N. Premal T. Vaidya R. and Sheth J. Association of Vitamin D3 levels with glycemic control in Type 2 diabetes subjects from Gujarati population-India. Molecular Cytogenetics. 2014,7(1):36. doi.org/ 10.1186/1755-8166-7-S1-P36.

  • Patel NR. Patel HL. Gunjaliya AP. Prevalence of metabolic syndrome in higher socioeconomic class of Ahmedabad , Gujarat, India. International Journal of Medical Science and Public Health. 2016;5:35-39. doi.org/ 10.5455/ijmsph.2016.0206201510.

  • Basu D. Yadav A. Beladiya JV. Mehta AA. Rationale and Design of Open labelled, Parallel, Randomized Trial of Vitamin D Therapy in Patients with Cardiometabolic disorders in Ahmedabad Population. International Journal of Pharmaceutical Research. 2020; 12(3):99-108. doi.org/ 10.31838/ijpr/2020.12.03.015.

  • Rothschild SK. Emery-Tiburcio EE. Mack LJ. et al. BRIGHTEN Heart: Design and baseline characteristics of a randomized controlled trial for minority older adults with depression and cardiometabolic syndrome. Contemporary Clinical Trials. 2016;48: 99-109. doi.org/ 10.1016/j.cct.2016.04.008.

  • Mounika S. Savitha G. Association of Periodontal Diseases and Metabolic Syndrome. Research Journal of Pharmacy and Technology. 2015;8(8):994-996. doi.org/ 10.5958/0974-360X.2015.00166.3.

  • Sharma SK. Research Methodology & Biostatistics : A Comprehensive Guide for Health Care Professionals, New Delhi, Elsevier.2017;pp.140. 26. Charan J. Biswas T. How to calculate sample size for different study designs in medical research?,Indian Journal of Psychological Medicine. 2013;35:121-126.

  • Kuchay MS. Laway BA. Bashir MI. et al. Effect of Vitamin D supplementation on glycemic parameters and progression of prediabetes to diabetes: A 1 year , open-label randomised study. Indian Journal of Endocrinology and Metabolism.2015;19: 387-392. doi.org/ 10.4103/2230-8210.152783.

  • Do-Jin Kim. Jong-HyuckKim. Relationship between Cardiopulmonary function Metabolic Syndrome Indices. Research Journal of Pharmacy and Technology. 2017;10(11):3868-3872. doi.org/ 10.5958/0974-360X.2017.00702.8.

  • Yarparvar. Elmadfa I. Djazayery A. Abdollahi Z.Salehi F.Heshmat R. The Effects of Vitamin D Supplementation on Lipid and Inflammatory Profile of Healthy Adolescent Boys: A Randomized Controlled Trial. Nutrients. 2020,12:1213. doi.org/ 10.3390/nu12051213.

  • Chinawale CG. Parmar DV. Kavathia P. Rangnani T. Thakkar J. Kartha G. Metabolic syndrome among adults of surendranagar District of Saurashtra,Gujarat: A cross sectional Study. Indian Journal of Community Medicine. 2018;43:24-8. doi.org/ 10.4103/ijcm.IJCM_339_16.

  • Salekzamani S. Mehralizadeh H. Ghezel A. et al Effect of high-dose vitamin D supplementation on cardiometabolic risk factors in subjects with metabolic syndrome: a randomized controlled double-blind clinical trial. Journal of Endocrinological Investigation. 2016;39: 1303-1313. doi.org/ 10.1007/s40618-016-0507-8.

  • Pfeifer M. Begerow B. Minne HW. et al Effects of a short term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. The Journal of Clinical Endocrinology and Metabolism. 2001; 86 (4) :1633–1637. doi.org/ 10.1210/jcem.86.4.7393.

  • Tavakoli F. Namakin K. and Zardast M. Vitamin D supplementation and High Density Lipoprotein Cholesterol: A Study in Healthy School Children. Iranian Journal of Pediatrices.2016;26: e3311. doi.org/ 10.5812/ijp.3311.

  • Jastrzebski Z.Kortas J.Kaczor K.Antosiewicz J. Vitamin D Supplementation Causes a Decrease in Blood Cholesterol in Professional Rowers. Journal of Nutritional Science and Vitaminology. 2016;62(2):88-92. doi.org/ 10.3177/jnsv.62.88.

  • Ryu OH. Lee S. Yu J. et al A prospective randomized controlled trial of the effects of vitamin D supplementation on long term glycemic control in type 2 diabetes mellitus of Korea. Korea Endocrinology and Metabolism.2014; 61:167-76. doi.org/ 10.1507/endocrj.ej13-0356.

  • Wood AD. Secombes KR. Thies F. Aucott L. Black AJ. et al Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: aparallel-group, double-blind, placebo-controlled RCT. Journal of Clinical Endocrinology & Metabolism. 2012;97:3557–3568. doi.org/ 10.1210/jc.2012-2126.

  • Amrein K. Scherkl M. Hoffman M. Sommeregger SN. Kostenberger M.Berisha AT. etal. Vitamin D deficiency 2.0: an update on the current status worldwide. European Journal of Clinical Nutrition. 2020;74:1498-1513. doi.org/ 10.1038/s41430-020-0558-y.

  • Lozano JMR. and Romero JMC. Effects on lipid profile of supplementation with vitamin D in type 2 diabetic patients with vitamin D deficiency. Therapeutic Advances in Endocrinology and Metabolism. 2015;6(6):245-248. doi.org/ 10.1177/2042018815599874.


Abstract Views: 264

PDF Views: 0




  • Effect of Vitamin D Supplementation in Patients with Cardiometabolic Disorders- a Clinical Study in Ahmedabad Population

Abstract Views: 264  |  PDF Views: 0

Authors

Debdoot Basu
L.M. College of Pharmacy, Gujarat Technological University, Ahmedabad, Gujarat, India
Anant Yadav
Tej Hospital, Ahmedabad, Gujarat, India
Anita A. Mehta
L.M. College of Pharmacy, Gujarat Technological University, Ahmedabad, Gujarat, India

Abstract


Vitamin D deficiency and cardiometabolic disorders are very much widespread in worldwide, India and Ahmedabad region of Gujarat. It was the first study conducted among Gujarati ethnic group of Ahmedabad region, India. The aim of the study was to assess the effects of vitamin D supplementation on cardiometabolic disorders with vitamin D deficiency. The study was performed as an open labeled, randomized, parallel-group, single centric and prospective design at Tej Hospital, Ahmedabad, Gujarat. The dosage regimen of vitamin D supplementation was 60,000 IU/ week for 4 weeks and then 60,000IU once a month for 12 months. Our results showed that vitamin D supplementation causes significant decrease in systolic blood pressure (SBP) at 6 and 12 months as well as significant decrease in triglycerides (TG),very low density lipoprotein (VLDL), fasting blood glucose (FBG), post prandial blood glucose (PPBG) and glycosylated haemoglobin ( HbA1c) with significant increase in 25(OH)D level in vitamin D group at 12 months as compared with non-vitamin D group .Our findings supported that vitamin D deficiency may be a potential risk factor for cardiometabolic disorders and the dosage regimen of vitamin D supplementation is enough to achieve sufficiency and maintain 25(OH)D level which ultimately causes improvement in cardiometabolic disorders.

Keywords


Cardiometabolic disorders, Vitamin D, Clinical Study, Gujarati, Ahmedabad.

References